This inventor holds 1 USPTO granted patent. Top assignee: Recordati S.a. Chemical and Pharmaceutical Company. Active years: 1990.
Company Filing History:
Years Active: 1990
Title: Gabriel Kraziani: Innovator in Antihypertensive Compounds
Introduction
Gabriel Kraziani is a notable inventor based in Arese, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antihypertensive compounds. His work focuses on creating innovative solutions for cardiovascular health.
Latest Patents
Kraziani holds a patent for "Novel asymmetric diesters of 1,4-dihydro-2,6-dimethylpyridine-3,5-dicarboxylic acid." This patent, which is classified under the general formula (I), describes a new class of asymmetric diesters that exhibit antihypertensive and coronary dilating properties. The compound is synthesized from specific aldehydes and esters, showcasing Kraziani's expertise in chemical synthesis.
Career Highlights
Kraziani is currently employed at Recordati S.a., a prominent chemical and pharmaceutical company. His role involves research and development, where he applies his knowledge to create effective pharmaceutical products. His innovative approach has led to advancements in the treatment of hypertension.
Collaborations
Throughout his career, Kraziani has collaborated with esteemed colleagues such as Giorgio Bianchi and Dante Nardi. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Gabriel Kraziani's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a key inventor in the industry. His work continues to impact the development of effective treatments for cardiovascular conditions.